影响因子:
7.6
ISSN:
print: 2572-9241
研究领域:
Medicine-Hematology
自引率:
4.50%
Gold OA文章占比:
72.03%
原创研究文献占比:
90.48%
SCI收录类型:
Science Citation Index Expanded (SCIE) || Scopus (CiteScore) || Directory of Open Access Journals (DOAJ)
期刊介绍英文:
HemaSphere, as a publication, is dedicated to disseminating the outcomes of profoundly pertinent basic, translational, and clinical research endeavors within the field of hematology. The journal actively seeks robust studies that unveil novel discoveries with significant ramifications for hematology. In addition to original research, HemaSphere features review articles and guideline articles that furnish lucid synopses and discussions of emerging developments, along with recommendations for patient care. Positioned as the foremost resource in hematology, HemaSphere augments its offerings with specialized sections like HemaTopics and HemaPolicy. These segments engender insightful dialogues covering a spectrum of hematology-related topics, including digestible summaries of pivotal articles, updates on new therapies, deliberations on European policy matters, and other noteworthy news items within the field. Steering the course of HemaSphere are Editor in Chief Jan Cools and Deputy Editor in Chief Claire Harrison, alongside the guidance of an esteemed Editorial Board comprising international luminaries in both research and clinical realms, each representing diverse areas of hematologic expertise.
期刊介绍中文:
《HemaSphere》发表高度相关的血液学基础、转化和临床研究成果。期刊主要寻找报告对血液学领域具有重大影响的新颖发现的强有力的研究。评论文章和指南文章提供了对新发展的清晰概述和讨论以及患者护理的建议。 该期刊​是首要的血液学信息资源,该期刊的 HemaTopics 和 HemaPolicy 部分进一步增强了这一资源。这些部分提供了与血液学相关的所有方面的深入讨论,包括重要文章的摘要、新疗法的报告、欧洲政策的讨论以及其他血液学新闻。
CiteScore:
CiteScoreSJRSNIPCiteScore排名
6.11.1911.119
学科
排名
百分位
大类:Medicine
小类:Hematology
37 / 137
73%
发文信息
中科院SCI期刊分区
大类 小类 TOP期刊 综述期刊
2区 医学
2区 血液学 HEMATOLOGY
WOS期刊分区
学科分类
Q1HEMATOLOGY
历年影响因子
2021年8.3000
2022年6.6000
2023年7.6000
历年发表
2017年17
2018年288
2019年2483
2020年137
2021年301
2022年2776
投稿信息
出版语言:
English
出版国家(地区):
United States
审稿时长:
7 weeks
出版商:
Wolters Kluwer Health

HemaSphere - 最新文献

Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial

Pub Date : 2024-11-20 DOI: 10.1002/hem3.70052 Elias K. Mai, Axel Nogai, Henk M. Lokhorst, Bronno van der Holt, Sonja Zweegman, Katja C. Weisel, Sandra Croockewit, Anna Jauch, Jens Hillengass, Marian Stevens-Kroef, Marc S. Raab, Annemiek Broijl, Gerard M. J. Bos, Peter Brossart, Paula Ypma, Christine Hanoun, Uta Bertsch, Thomas Hielscher, Hans J. Salwender, Christoph Scheid, Hartmut Goldschmidt, Pieter Sonneveld

The incidence and clinical significance of monoclonal and oligoclonal protein bands in multiple myeloma patients after BCMA–CAR-T cell therapy: A retrospective study based on LEGEND-2

Pub Date : 2024-11-19 DOI: 10.1002/hem3.70054 Rui Liu, Gongzhizi Gao, Hongli Chen, Ruijun Dong, Wanggang Zhang, Wanhong Zhao, Jie Liu, Jianli Wang, Bo Lei, Baiyan Wang, Jiali Liu, Xuezhu Xu, Zujie Lin, Ruoyu Yang, Yiwen Wang, Aili He, Fangxia Wang, Ju Bai

Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population-based screening study

Pub Date : 2024-11-19 DOI: 10.1002/hem3.70046 Sæmundur Rögnvaldsson, Jón Þ. Óskarsson, Sigrun Thorsteinsdóttir, Malin Hultcrantz, Robert Palmason, Ingigerdur S. Sverrisdottir, Elias Eythorsson, Thorir E. Long, Isleifur Olafsson, Ingunn Thorsteinsdottir, Brynjar Vidarsson, Pall T. Onundarson, Bjarni A. Agnarsson, Margret Sigurdardottir, Asbjorn Jonsson, Brian G. M. Durie, Stephen Harding, Ola Landgren, Thorvardur J. Love, Sigurdur Y. Kristinsson
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信